Michael Lourenco Costa is CFO & VP +1 at Sabra Health Care REIT, Inc. (SBRA). They have made 1 open-market trade across 1 company since 2023, most recently 2026-08-31.
CIK 0001838630
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SBRA | 469,879 | $9.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SBRA | BUY | 2023-09-01 | 2023-09-05 | $12.63 | $25K | +5.8% | +9.7% | +14.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.